152 related articles for article (PubMed ID: 29414453)
1. Physiological predictors of Hypoxic Challenge Testing (HCT) outcomes in Interstitial Lung Disease (ILD).
Barratt SL; Shaw J; Jones R; Bibby A; Adamali H; Mustfa N; Cliff I; Stone H; Chaudhuri N
Respir Med; 2018 Feb; 135():51-56. PubMed ID: 29414453
[TBL] [Abstract][Full Text] [Related]
2. Flight assessment in patients with respiratory disease: hypoxic challenge testing vs. predictive equations.
Martin SE; Bradley JM; Buick JB; Bradbury I; Elborn JS
QJM; 2007 Jun; 100(6):361-7. PubMed ID: 17525132
[TBL] [Abstract][Full Text] [Related]
3. Exertional hypoxemia is more severe in fibrotic interstitial lung disease than in COPD.
Du Plessis JP; Fernandes S; Jamal R; Camp P; Johannson K; Schaeffer M; Wilcox PG; Guenette JA; Ryerson CJ
Respirology; 2018 Apr; 23(4):392-398. PubMed ID: 29193512
[TBL] [Abstract][Full Text] [Related]
4. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
[TBL] [Abstract][Full Text] [Related]
5. The performance of the GAP model in patients with rheumatoid arthritis associated interstitial lung disease.
Morisset J; Vittinghoff E; Lee BY; Tonelli R; Hu X; Elicker BM; Ryu JH; Jones KD; Cerri S; Manfredi A; Sebastiani M; Gross AJ; Ley B; Wolters PJ; King TE; Kim DS; Collard HR; Lee JS
Respir Med; 2017 Jun; 127():51-56. PubMed ID: 28502419
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers to identify ILD and predict lung function decline in scleroderma lung disease or idiopathic pulmonary fibrosis.
Kennedy B; Branagan P; Moloney F; Haroon M; O'Connell OJ; O'Connor TM; O'Regan K; Harney S; Henry MT
Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):228-36. PubMed ID: 26422568
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
[TBL] [Abstract][Full Text] [Related]
8. The prediction of in-flight hypoxaemia using non-linear equations.
Billings CG; Wei HL; Thomas P; Linnane SJ; Hope-Gill BD
Respir Med; 2013 Jun; 107(6):841-7. PubMed ID: 23523199
[TBL] [Abstract][Full Text] [Related]
9. Nocturnal hypoxaemia is associated with adverse outcomes in interstitial lung disease.
Troy LK; Young IH; Lau EMT; Wong KKH; Yee BJ; Torzillo PJ; Corte TJ
Respirology; 2019 Oct; 24(10):996-1004. PubMed ID: 30933419
[TBL] [Abstract][Full Text] [Related]
10. Understanding the determinants of health-related quality of life in rheumatoid arthritis-associated interstitial lung disease.
Natalini JG; Swigris JJ; Morisset J; Elicker BM; Jones KD; Fischer A; Collard HR; Lee JS
Respir Med; 2017 Jun; 127():1-6. PubMed ID: 28502413
[TBL] [Abstract][Full Text] [Related]
11. Effect of simulated commercial flight on oxygenation in patients with interstitial lung disease and chronic obstructive pulmonary disease.
Seccombe LM; Kelly PT; Wong CK; Rogers PG; Lim S; Peters MJ
Thorax; 2004 Nov; 59(11):966-70. PubMed ID: 15516473
[TBL] [Abstract][Full Text] [Related]
12. Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation.
Layton AM; Armstrong HF; Kim HP; Meza KS; D'Ovidio F; Arcasoy SM
Respir Med; 2017 May; 126():59-67. PubMed ID: 28427551
[TBL] [Abstract][Full Text] [Related]
13. A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.
Khadawardi H; Mura M
Respirology; 2017 Apr; 22(3):501-507. PubMed ID: 27862639
[TBL] [Abstract][Full Text] [Related]
14. Predicting Mortality in Systemic Sclerosis-Associated Interstitial Lung Disease Using Risk Prediction Models Derived From Idiopathic Pulmonary Fibrosis.
Ryerson CJ; O'Connor D; Dunne JV; Schooley F; Hague CJ; Murphy D; Leipsic J; Wilcox PG
Chest; 2015 Nov; 148(5):1268-1275. PubMed ID: 25996795
[TBL] [Abstract][Full Text] [Related]
15. Hypoxaemia in patients with pulmonary arterial hypertension during simulated air travel.
Burns RM; Peacock AJ; Johnson MK; Church AC
Respir Med; 2013 Feb; 107(2):298-304. PubMed ID: 23127571
[TBL] [Abstract][Full Text] [Related]
16. Pre-flight evaluation of adult patients with cystic fibrosis: a cross-sectional study.
Edvardsen E; Akerø A; Skjønsberg OH; Skrede B
BMC Res Notes; 2017 Feb; 10(1):84. PubMed ID: 28166839
[TBL] [Abstract][Full Text] [Related]
17. Multi-dimensional scores to predict mortality in patients with idiopathic pulmonary fibrosis undergoing lung transplantation assessment.
Fisher JH; Al-Hejaili F; Kandel S; Hirji A; Shapera S; Mura M
Respir Med; 2017 Apr; 125():65-71. PubMed ID: 28340864
[TBL] [Abstract][Full Text] [Related]
18. Performance capacity evaluated using the 6-minute walk test: 5-year results in patients with diffuse systemic sclerosis and initial interstitial lung disease.
Rizzi M; Sarzi-Puttini P; Airoldi A; Antivalle M; Battellino M; Atzeni F
Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S142-7. PubMed ID: 26339893
[TBL] [Abstract][Full Text] [Related]
19. The hypoxia challenge test does not accurately predict hypoxia in flight in ex-preterm neonates.
Resnick SM; Hall GL; Simmer KN; Stick SM; Sharp MJ
Chest; 2008 May; 133(5):1161-6. PubMed ID: 18198246
[TBL] [Abstract][Full Text] [Related]
20. Healthcare Resources Utilization and Costs of Patients with Non-IPF Progressive Fibrosing Interstitial Lung Disease Based on Insurance Claims in the USA.
Olson AL; Maher TM; Acciai V; Mounir B; Quaresma M; Zouad-Lejour L; Wells CD; De Loureiro L
Adv Ther; 2020 Jul; 37(7):3292-3298. PubMed ID: 32451950
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
